GIM
GILD icon

Generali Investments Management’s Gilead Sciences GILD Stock Holding History

Generali Investments Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.59M Buy
20,496
+4,941
+32% +$651K 0.56% 41
2026
Q1 		$2.17M Sell
15,555
-11,474
-42% -$1.61M 0.5% 41
2025
Q4 		$3.32M Buy
27,029
+7,424
+38% +$902K 0.66% 37
2025
Q3 		$2.18M Buy
19,605
+6,067
+45% +$690K 0.45% 47
2025
Q2 		$1.5M Buy
13,538
+579
+4% +$61.6K 0.34% 68
2025
Q1 		$1.45M Buy
12,959
+1,104
+9% +$114K 0.41% 66
2024
Q4 		$1.1M Buy
+11,855
New +$1.07M 0.28% 72

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Generali Investments Management's GILD Position: Q2 2026 in Review

Generali Investments Management increased its Gilead Sciences (GILD) stake by 32% in Q2 2026, buying an estimated $651K and bringing the position to 20,496 shares worth $2.59M. The position accounts for 0.56% of the portfolio, ranked #41.

Generali Investments Management first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.32M in Q4 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Generali Investments Management held 20,496 shares of Gilead Sciences worth $2.59M as of Q2 2026.
  • Generali Investments Management bought 4,941 Gilead Sciences shares in Q2 2026, an estimated $651K.
  • Gilead Sciences made up 0.56% of Generali Investments Management's portfolio in Q2 2026, its #41 holding.
  • Generali Investments Management first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Generali Investments Management's Gilead Sciences position peaked at $3.32M in Q4 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Generali Investments Management's 13F filing for Q2 2026, filed 10 Jul 2026.